Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620326611.pdf